abraham+pinter - Available Technologies | Rutgers University Innovation Ventures

Search Results - abraham+pinter

2 Results Sort By:
Serological/ELISA-Based Test For COVID-19
Invention Summary: The unprecedented outbreak and spread of SARS-CoV-2 has led to rapid development of the COVID-19 pandemic. Since its beginning in 2020, the virus has rapidly evolved due to its spread, causing the generation of novel variants like Omicron more recently. Thus, there is still an unmet need for more specific, reliable, and high throughput...
Published: 3/14/2023   |   Inventor(s): Maria Gennaro, Abraham Pinter
Category(s): Technology Classifications > Healthcare & Life Sciences, Technology Classifications > COVID-19
Therapeutic Human Monoclonal Antibody (HUMAB) with Extremely Potent and Broadly Neutralizing Activity for Omicron and Other CoV-2 Variants
­â€‹ Potent breadth and cross-reactivity of novel CoV2 neutralizing human monoclonal antibody that can neutralize the highly immune-evasive BQ.1/BQ.1.1 variants that are currently responsible for ≅ 50% of CoV2 infection in US. Invention Summary: The emergence of highly immune evasive SARS-CoV2 escape mutants require an immediate response...
Published: 1/27/2023   |   Inventor(s): Alok Choudhary, Abraham Pinter
Keywords(s): Antibodies, Respiratory Disease
Category(s): Technology Classifications > Therapeutics, Technology Classifications > Healthcare & Life Sciences, Technology Classifications > COVID-19, Technology Classifications > Diagnostics